Global Single Nucleotide Polymorphism SNP Genotyping Market Report 2024

Single Nucleotide Polymorphism (SNP) Genotyping Global Market Report 2024 – By Product (Consumables, Instruments, services), By Technology (TaqMan SNP Genotyping, Mass Array SNP Genotyping, SNP Gene Chip Arrays, Other Technologies), By Application (Animal Genetics, Plant Improvement, Diagnostic Research, Pharmaceuticals And Pharmacogenomics, Agricultural Biotechnology, Other Applications) – Market Size, Trends, And Global Forecast 2024-2033

Single Nucleotide Polymorphism (SNP) Genotyping Global Market Report 2024

Starting Price : $5000.00 | Pages : | Published : January 2024 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options
Request Sample
Request For Discount
FAQs
Customise Your Report
Request For Proposal
Request For Regional Data

Need assistance or more information before the purchase?

Enquire Before Buying
Single Nucleotide Polymorphism (SNP) Genotyping Global Market Report 2024

Proud Members Of

checkslacipN checkaoirsN checkscipN
Description Table Of Contents Tables & Figures Market Insights Related Reports

Single Nucleotide Polymorphism (SNP) Genotyping Market Definition And Segments

Single nucleotide polymorphism (SNP) genotyping refers to a procedure that locates and describes genetic variants at the level of specific DNA nucleotides. It identifies individual SNPs, which are single-base changes in DNA sequences, and it is essential for understanding the genetic variations linked to diseases, traits, and population studies.

The main products of single nucleotide polymorphism (SNP) genotyping are consumables, instruments, and services. Consumables refer to commodities that people and businesses consume or use up and need to be replaced regularly, such as food and home supplies. The various technologies include TaqMan SNP genotyping, mass array SNP genotyping, SNP gene chip arrays, and others used in various applications such as animal genetics, plant improvement, diagnostic research, pharmaceuticals and pharmacogenomics, agricultural biotechnology, and others.

The single nucleotide polymorphism (SNP) genotyping market covered in this report is segmented –

1) By Product: Consumables, Instruments, services

2) By Technology: TaqMan SNP Genotyping, Mass Array SNP Genotyping, SNP Gene Chip Arrays, Other Technologies

3) By Application: Animal Genetics, Plant Improvement, Diagnostic Research, Pharmaceuticals And Pharmacogenomics, Agricultural Biotechnology, Other Applications

The single nucleotide polymorphism (SNP) genotyping market size has grown exponentially in recent years. It will grow from $8.48 billion in 2023 to $10.24 billion in 2024 at a compound annual growth rate (CAGR) of 20.7%. The growth in the historic period can be attributed to increasing research in genomics, rise in genetic disorders, growth in personalized medicine, expanding pharmaceutical industry, and rising demand for molecular diagnostics.

The single nucleotide polymorphism (SNP) genotyping market size is expected to see rapid growth in the next few years. It will grow to $20.6 billion in 2028 at a compound annual growth rate (CAGR) of 19.1%. The growth in the forecast period can be attributed to growing applications in disease research, a rise in demand for precision medicine, expanding biobanking initiatives, the surge in genetic testing, and rising adoption in agriculture for crop improvement. Major trends in the forecast period include increasing use of next-generation sequencing (NGS), rising demand for SNP genotyping in pharmacogenomics, the emergence of direct-to-consumer genetic testing, focus on automation, and high-throughput genotyping platforms.

The Rising Role Of SNP Genotyping In Chronic Disease Management

The increasing burden of chronic conditions is expected to propel the growth of the single nucleotide polymorphism (SNP) genotyping market going forward. Chronic conditions are problems that last a year or longer, necessitating continuing medical care, restricting everyday activities, or both. Single-nucleotide polymorphism (SNP) genotyping is essential for identifying genetic predispositions and promoting personalized medicine due to the increased prevalence of chronic diseases. For instance, in January 2023, according to the National Center for Biotechnology Information (NCBI), a US-based National Library of Medicine, there will be 142.66 million people with chronic diseases worldwide by the year 2050, up from 71.522 million in 2020. Therefore, the increasing burden of chronic conditions drives the growth of the single nucleotide polymorphism (SNP) genotyping systems market.

The Driving Force Of Funding In SNP Genotyping Market Expansion

Rising funds for genomic research are expected to propel the growth of the single nucleotide polymorphism (SNP) genotyping market going forward. Funds for genomic research refers to financial resources allocated, granted, or invested to support research activities in the field of genomics. Funds for genomic research play a pivotal role in advancing SNP studies by supporting diverse research initiatives, technology development, and collaborative efforts. For instance, National Human Genome Research Institute, a US-based government genomic research center received $604 million in 2020, $614 million in 2021, and $616 million in 2022. The 2023 budget proposes an allocation of $629 million for the institute. Additionally, In April 2021, according to the Association of American Medical Colleges, a US-based medical education center, the Biden administration is allocating $1.7 billion to enhance SARS-CoV-2 variant detection, monitoring, and mitigation, as well as to establish genomic sequencing infrastructure for future needs. Therefore, rising funds for genomic research are driving the growth of the single nucleotide polymorphism (SNP) genotyping market.

Major companies operating in the single nucleotide polymorphism (SNP) genotyping market report are Thermo Fischer Scientific Inc., Danaher Corporation, Roche Diagnostics Corporation, GE HealthCare Technologies Inc., Eurofins Genomics LLC, Beckman Coulter Inc., Bio-Rad Laboratories Inc., Qiagen N.V., Sigma-Aldrich Corporation, Agilent Technologies Inc., PerkinElmer Inc., Illumina Inc., Promega Corporation, GenScript Biotech Corporation, Integrated DNA Technologies Inc., LGC Ltd., Sequenom Inc., Fluidigm Corporation, Agendia Inc., Nugen Technologies Inc., BioChain Institute Inc., Standard BioTools Inc., Oxford Gene Technology, Affymetrix Inc., PREMIER Biosoft International Inc., GenoLogics, Rubicon Genomics Inc., Xcelris Genomics, Douglas Scientific LLC, Golden Helix Inc.

Neogen Corporation And Gencove Transforming SNP Genotyping With InfiniSEEK

Technological solutions are a key trend gaining popularity in the single nucleotide polymorphism (SNP) genotyping market. Major companies operating in the single nucleotide polymorphism (SNP) genotyping market are introducing technologically advanced solutions to sustain their position in the market. For instance, in May 2022, Neogen Corporation, a US-based food safety company that provides solutions for the agriculture, animal protein, food, and beverage industries, and Gencove, a US-based provider of sequencing solutions, launched InfiniSEEK. It is the first complete genome and genotyping tool for cattle breeders. InfiniSEEK's thorough validation shows that low-pass genome-wide sequencing is more than 99% concordant with deep whole-genome sequencing and can provide even higher clinical-grade accuracy in some areas of interest.

Revolutionizing Coronary Heart Disease Diagnosis With AI And Biomarkers

Major companies operating in the single nucleotide polymorphism (SNP) genotyping market are developing biomarkers that are useful in coronary heart disease detection to increase their profitability in the market. Single nucleotide polymorphism (SNP) biomarkers associated with coronary heart disease (CHD) detection are specific genetic variations that have been identified through genomic research and are linked to an increased risk or susceptibility to coronary heart disease. For instance, in February 2023, Cardio Diagnostics, a US-based biotechnology company launched PrecisionCHD. PrecisionCHD is an AI-driven blood test that utilizes a combination of epigenetic (DNA methylation) and genetic (single nucleotide polymorphism) biomarkers to detect CHD. The test employs a machine-learning model to achieve over 75% sensitivity for both genders, providing a non-invasive option for in-office or at-home blood sample collection. This eliminates the necessity for traditional tests like stress tests, ensuring objectivity by relying solely on biomarkers, rather than self-reported patient data.

Diasorin’s Game-Changing Acquisition Of Luminex

In July 2021, DiaSorin S.p.A., an Italy-based manufacturer of in vitro diagnostic reagent kits for molecular and immunodiagnostics, acquired Luminex Corporation for approximately $1.8 billion. With this acquisition, Luminex aims to broaden the scope of its applications across the Life Science sector, facilitating access to academic and scientific research, strengthening collaboration with the biopharmaceutical industry, and boosting the availability of clinical multiplexing assays for upcoming value-based care initiatives. Luminex Corporation is a US-based biotechnology company that offers single nucleotide polymorphism (SNP) genotyping technology.

North America was the largest region in the single nucleotide polymorphism (SNP) genotyping market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the single nucleotide polymorphism (SNP) genotyping market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the single nucleotide polymorphism (SNP) genotyping market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The single nucleotide polymorphism (SNP) genotyping market includes revenues earned by providing sample collection, DNA extraction, high-resolution melting analysis, and related next-generation sequencing. The market value includes the value of related goods sold by the service provider or included within the service offering. The single nucleotide polymorphism (SNP) genotyping market consists of sales of mass spectrometry-based SNP genotyping and allele-specific PCR. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The single nucleotide polymorphism (SNP) genotyping market research report is one of a series of new reports from The Business Research Company that provides single nucleotide polymorphism (SNP) genotyping market statistics, including the single nucleotide polymorphism (SNP) genotyping industry's global market size, regional shares, competitors with a single nucleotide polymorphism (SNP) genotyping market share, detailed single nucleotide polymorphism (SNP) genotyping market segments, market trends and opportunities, and any further data you may need to thrive in the single nucleotide polymorphism (SNP) genotyping industry. This single nucleotide polymorphism (SNP) genotyping market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Single Nucleotide Polymorphism (SNP) Genotyping Market Report Scope
Report AttributeDetails
Market Size Value In 2024 $10.24 billion
Revenue Forecast In 2033 $20.6 billion
Growth Rate CAGR of 19.1% from 2024 to 2033
Base Year For Estimation 2023
Actual Estimates/Historical Data 2018-2023
Forecast Period 2024 - 2028 - 2033
Market Representation Revenue in USD Billion and CAGR from 2024 to 2033
Segments Covered 1) By Product: Consumables, Instruments, services
2) By Technology: TaqMan SNP Genotyping, Mass Array SNP Genotyping, SNP Gene Chip Arrays, Other Technologies
3) By Application: Animal Genetics, Plant Improvement, Diagnostic Research, Pharmaceuticals And Pharmacogenomics, Agricultural Biotechnology, Other Applications
Regional Scope Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Country Scope Australia; China; India; Indonesia; Japan; South Korea; Bangladesh; Thailand; Vietnam; Malaysia; Singapore; Philippines; Hong Kong; New Zealand; USA; Canada; Mexico; Brazil; Chile; Argentina; Colombia; Peru; France; Germany; UK; Austria; Belgium; Denmark; Finland; Ireland; Italy; Netherlands; Norway; Portugal; Spain; Sweden; Switzerland; Russia; Czech Republic; Poland; Romania; Ukraine; Saudi Arabia; Israel; Iran; Turkey; UAE; Egypt; Nigeria; South Africa
Key Companies Profiled Thermo Fischer Scientific Inc.; Danaher Corporation; Roche Diagnostics Corporation; GE HealthCare Technologies Inc.; Eurofins Genomics LLC; Beckman Coulter Inc.; Bio-Rad Laboratories Inc.; Qiagen N.V.; Sigma-Aldrich Corporation; Agilent Technologies Inc.; PerkinElmer Inc.; Illumina Inc.; Promega Corporation; GenScript Biotech Corporation; Integrated DNA Technologies Inc.; LGC Ltd.; Sequenom Inc.; Fluidigm Corporation; Agendia Inc.; Nugen Technologies Inc.; BioChain Institute Inc.; Standard BioTools Inc.; Oxford Gene Technology; Affymetrix Inc.; PREMIER Biosoft International Inc.; GenoLogics; Rubicon Genomics Inc.; Xcelris Genomics; Douglas Scientific LLC; Golden Helix Inc.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Single Nucleotide Polymorphism (SNP) Genotyping Market Characteristics

    3. Single Nucleotide Polymorphism (SNP) Genotyping Market Trends And Strategies

    4. Single Nucleotide Polymorphism (SNP) Genotyping Market - Macro Economic Scenario

    4.1. Impact Of High Inflation On The Market

    4.2. Ukraine-Russia War Impact On The Market

    4.3. COVID-19 Impact On The Market

    5. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size and Growth

    5.1. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Drivers and Restraints

    5.1.1. Drivers Of The Market

    5.1.2. Restraints Of The Market

    5.2. Global Single Nucleotide Polymorphism (SNP) Genotyping Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)

    5.3. Global Single Nucleotide Polymorphism (SNP) Genotyping Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

    6. Single Nucleotide Polymorphism (SNP) Genotyping Market Segmentation

    6.1. Global Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Consumables

    Instruments

    Services

    6.2. Global Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    TaqMan SNP Genotyping

    Mass Array SNP Genotyping

    SNP Gene Chip Arrays

    Other Technologies

    6.3. Global Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Animal Genetics

    Plant Improvement

    Diagnostic Research

    Pharmaceuticals And Pharmacogenomics

    Agricultural Biotechnology

    Other Applications

    7. Single Nucleotide Polymorphism (SNP) Genotyping Market Regional And Country Analysis

    7.1. Global Single Nucleotide Polymorphism (SNP) Genotyping Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    7.2. Global Single Nucleotide Polymorphism (SNP) Genotyping Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8. Asia-Pacific Single Nucleotide Polymorphism (SNP) Genotyping Market

    8.1. Asia-Pacific Single Nucleotide Polymorphism (SNP) Genotyping Market Overview

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.3. Asia-Pacific Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.4. Asia-Pacific Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    9. China Single Nucleotide Polymorphism (SNP) Genotyping Market

    9.1. China Single Nucleotide Polymorphism (SNP) Genotyping Market Overview

    9.2. China Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.3. China Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.4. China Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    10. India Single Nucleotide Polymorphism (SNP) Genotyping Market

    10.1. India Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.2. India Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.3. India Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11. Japan Single Nucleotide Polymorphism (SNP) Genotyping Market

    11.1. Japan Single Nucleotide Polymorphism (SNP) Genotyping Market Overview

    11.2. Japan Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.3. Japan Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.4. Japan Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12. Australia Single Nucleotide Polymorphism (SNP) Genotyping Market

    12.1. Australia Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.2. Australia Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.3. Australia Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13. Indonesia Single Nucleotide Polymorphism (SNP) Genotyping Market

    13.1. Indonesia Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.2. Indonesia Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.3. Indonesia Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14. South Korea Single Nucleotide Polymorphism (SNP) Genotyping Market

    14.1. South Korea Single Nucleotide Polymorphism (SNP) Genotyping Market Overview

    14.2. South Korea Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.3. South Korea Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.4. South Korea Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15. Western Europe Single Nucleotide Polymorphism (SNP) Genotyping Market

    15.1. Western Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Overview

    15.2. Western Europe Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.3. Western Europe Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.4. Western Europe Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16. UK Single Nucleotide Polymorphism (SNP) Genotyping Market

    16.1. UK Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.2. UK Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.3. UK Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17. Germany Single Nucleotide Polymorphism (SNP) Genotyping Market

    17.1. Germany Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.2. Germany Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.3. Germany Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18. France Single Nucleotide Polymorphism (SNP) Genotyping Market

    18.5. France Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.6. France Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.7. France Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19. Italy Single Nucleotide Polymorphism (SNP) Genotyping Market

    19.9. Italy Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.10. Italy Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.11. Italy Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20. Spain Single Nucleotide Polymorphism (SNP) Genotyping Market

    20.13. Spain Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.14. Spain Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.15. Spain Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21. Eastern Europe Single Nucleotide Polymorphism (SNP) Genotyping Market

    21.1. Eastern Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Overview

    21.2. Eastern Europe Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.3. Eastern Europe Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.4. Eastern Europe Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22. Russia Single Nucleotide Polymorphism (SNP) Genotyping Market

    22.1. Russia Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.2. Russia Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.3. Russia Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23. North America Single Nucleotide Polymorphism (SNP) Genotyping Market

    23.1. North America Single Nucleotide Polymorphism (SNP) Genotyping Market Overview

    23.2. North America Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.3. North America Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.4. North America Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24. USA Single Nucleotide Polymorphism (SNP) Genotyping Market

    24.1. USA Single Nucleotide Polymorphism (SNP) Genotyping Market Overview

    24.2. USA Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.3. USA Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.4. USA Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25. Canada Single Nucleotide Polymorphism (SNP) Genotyping Market

    25.1. Canada Single Nucleotide Polymorphism (SNP) Genotyping Market Overview

    25.2. Canada Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.3. Canada Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.4. Canada Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26. South America Single Nucleotide Polymorphism (SNP) Genotyping Market

    26.1. South America Single Nucleotide Polymorphism (SNP) Genotyping Market Overview

    26.2. South America Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.3. South America Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.4. South America Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27. Brazil Single Nucleotide Polymorphism (SNP) Genotyping Market

    27.1. Brazil Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.2. Brazil Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.3. Brazil Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28. Middle East Single Nucleotide Polymorphism (SNP) Genotyping Market

    28.1. Middle East Single Nucleotide Polymorphism (SNP) Genotyping Market Overview

    28.2. Middle East Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.3. Middle East Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.4. Middle East Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29. Africa Single Nucleotide Polymorphism (SNP) Genotyping Market

    29.1. Africa Single Nucleotide Polymorphism (SNP) Genotyping Market Overview

    29.2. Africa Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.3. Africa Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.4. Africa Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    30. Single Nucleotide Polymorphism (SNP) Genotyping Market Competitive Landscape And Company Profiles

    30.1. Single Nucleotide Polymorphism (SNP) Genotyping Market Competitive Landscape

    30.2. Single Nucleotide Polymorphism (SNP) Genotyping Market Company Profiles

    30.2.1. Thermo Fischer Scientific Inc.

    30.2.1.1. Overview

    30.2.1.2. Products and Services

    30.2.1.3. Strategy

    30.2.1.4. Financial Performance

    30.2.2. Danaher Corporation

    30.2.2.1. Overview

    30.2.2.2. Products and Services

    30.2.2.3. Strategy

    30.2.2.4. Financial Performance

    30.2.3. Roche Diagnostics Corporation

    30.2.3.1. Overview

    30.2.3.2. Products and Services

    30.2.3.3. Strategy

    30.2.3.4. Financial Performance

    30.2.4. GE HealthCare Technologies Inc.

    30.2.4.1. Overview

    30.2.4.2. Products and Services

    30.2.4.3. Strategy

    30.2.4.4. Financial Performance

    30.2.5. Eurofins Genomics LLC

    30.2.5.1. Overview

    30.2.5.2. Products and Services

    30.2.5.3. Strategy

    30.2.5.4. Financial Performance

    31. Single Nucleotide Polymorphism (SNP) Genotyping Market Other Major And Innovative Companies

    31.1. Beckman Coulter Inc.

    31.2. Bio-Rad Laboratories Inc.

    31.3. Qiagen N.V.

    31.4. Sigma-Aldrich Corporation

    31.5. Agilent Technologies Inc.

    31.6. PerkinElmer Inc.

    31.7. Illumina Inc.

    31.8. Promega Corporation

    31.9. GenScript Biotech Corporation

    31.10. Integrated DNA Technologies Inc.

    31.11. LGC Ltd.

    31.12. Sequenom Inc.

    31.13. Fluidigm Corporation

    31.14. Agendia Inc.

    31.15. Nugen Technologies Inc.

    32. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Competitive Benchmarking

    33. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Competitive Dashboard

    34. Key Mergers And Acquisitions In The Single Nucleotide Polymorphism (SNP) Genotyping Market

    35. Single Nucleotide Polymorphism (SNP) Genotyping Market Future Outlook and Potential Analysis

    35.1 Single Nucleotide Polymorphism (SNP) Genotyping Market In 2028 - Countries Offering Most New Opportunities

    35.2 Single Nucleotide Polymorphism (SNP) Genotyping Market In 2028 - Segments Offering Most New Opportunities

    35.3 Single Nucleotide Polymorphism (SNP) Genotyping Market In 2028 - Growth Strategies

    35.3.1 Market Trend Based Strategies

    35.3.2 Competitor Strategies

    36. Appendix

    36.1. Abbreviations

    36.2. Currencies

    36.3. Historic And Forecast Inflation Rates

    36.4. Research Inquiries

    36.5. The Business Research Company

    36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Table 3: Global Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 4: Global Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 5: Global Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 6: Global Single Nucleotide Polymorphism (SNP) Genotyping Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 7: Global Single Nucleotide Polymorphism (SNP) Genotyping Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 8: Asia-Pacific, Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 9: Asia-Pacific, Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 10: Asia-Pacific, Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 11: China, Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 12: China, Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 13: China, Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 14: India, Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 15: India, Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 16: India, Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 17: Japan, Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 18: Japan, Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 19: Japan, Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 20: Australia, Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 21: Australia, Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 22: Australia, Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 23: Indonesia, Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 24: Indonesia, Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 25: Indonesia, Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 26: South Korea, Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 27: South Korea, Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 28: South Korea, Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 29: Western Europe, Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 30: Western Europe, Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 31: Western Europe, Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 32: UK, Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 33: UK, Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 34: UK, Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 35: Germany, Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 36: Germany, Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 37: Germany, Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 38: France, Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 39: France, Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 40: France, Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 41: Italy, Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 42: Italy, Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 43: Italy, Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 44: Spain, Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 45: Spain, Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 46: Spain, Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 47: Eastern Europe, Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 48: Eastern Europe, Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 49: Eastern Europe, Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 50: Russia, Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 51: Russia, Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 52: Russia, Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 53: North America, Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 54: North America, Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 55: North America, Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 56: USA, Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 57: USA, Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 58: USA, Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 59: Canada, Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 60: Canada, Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 61: Canada, Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 62: South America, Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 63: South America, Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 64: South America, Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 65: Brazil, Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 66: Brazil, Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 67: Brazil, Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 68: Middle East, Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 69: Middle East, Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 70: Middle East, Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 71: Africa, Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 72: Africa, Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 73: Africa, Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 74: Thermo Fischer Scientific Inc. Financial Performance
  • Table 75: Danaher Corporation Financial Performance
  • Table 76: Roche Diagnostics Corporation Financial Performance
  • Table 77: GE HealthCare Technologies Inc. Financial Performance
  • Table 78: Eurofins Genomics LLC Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Figure 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Figure 3: Global Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 4: Global Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 5: Global Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 6: Global Single Nucleotide Polymorphism (SNP) Genotyping Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 7: Global Single Nucleotide Polymorphism (SNP) Genotyping Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 8: Asia-Pacific, Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 9: Asia-Pacific, Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 10: Asia-Pacific, Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 11: China, Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 12: China, Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 13: China, Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 14: India, Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 15: India, Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 16: India, Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 17: Japan, Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 18: Japan, Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 19: Japan, Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 20: Australia, Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 21: Australia, Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 22: Australia, Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 23: Indonesia, Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 24: Indonesia, Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 25: Indonesia, Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 26: South Korea, Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 27: South Korea, Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 28: South Korea, Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 29: Western Europe, Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 30: Western Europe, Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 31: Western Europe, Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 32: UK, Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 33: UK, Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 34: UK, Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 35: Germany, Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 36: Germany, Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 37: Germany, Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 38: France, Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 39: France, Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 40: France, Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 41: Italy, Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 42: Italy, Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 43: Italy, Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 44: Spain, Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 45: Spain, Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 46: Spain, Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 47: Eastern Europe, Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 48: Eastern Europe, Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 49: Eastern Europe, Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 50: Russia, Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 51: Russia, Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 52: Russia, Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 53: North America, Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 54: North America, Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 55: North America, Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 56: USA, Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 57: USA, Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 58: USA, Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 59: Canada, Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 60: Canada, Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 61: Canada, Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 62: South America, Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 63: South America, Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 64: South America, Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 65: Brazil, Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 66: Brazil, Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 67: Brazil, Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 68: Middle East, Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 69: Middle East, Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 70: Middle East, Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 71: Africa, Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 72: Africa, Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 73: Africa, Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 74: Thermo Fischer Scientific Inc. Financial Performance
  • Figure 75: Danaher Corporation Financial Performance
  • Figure 76: Roche Diagnostics Corporation Financial Performance
  • Figure 77: GE HealthCare Technologies Inc. Financial Performance
  • Figure 78: Eurofins Genomics LLC Financial Performance
Forecasting Till 2030: Opportunities And Strategies In The Global Value Based Care Payment Market – Includes Value Based Care Payment Market Analysis
Read More
How Will The Nuclear Medicine Market Grow In 2022?
Read More
What Is The Pediatric Imaging Market Overview In 2022?
Read More
Latest Healthcare Technology Management Market Growth Study 2022-2026 By The Business Research Company
Read More
The Business Research Company offers the hospital acquired infection control market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the multiplex assays market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the healthcare it consulting market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the renal biomarkers market research report 2022 with industry size, share, segments and market growth
Read More
Genotyping Global Market Report 2024 – By Product And Services (Instruments, Reagents And Kits, Bioinformatics, Genotyping Service), By Technology (Microarrays, Capillary Electrophoresis, Sequencing, Polymerase Chain Reaction, Matrix-Assisted Laser Desorption Or Ionization (Maldi-Tof) Mass Spectrometry, Other Technologies), By Application (Pharmacogenomics, Diagnostics and Personalized Medicine, Animal Genetics, Agricultural Biotechnology, Other Applications), By End-User (Pharmaceutical And Biopharmaceutical Companies, Diagnostics And Research Laboratories, Academic Institutes, Other End-Users) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Tissue Microarray Global Market Report 2024 – By Type (Immunohistochemistry, Fluorescent In Situ Hybridization, Frozen Tissue Array, Other Types), By Technology (Deoxyribonucleic Acid (DNA) Microarray, Polymerase Chain Reaction (PCR), Next-Generation Sequencing, Northern Blotting, Western Blotting), By Application (Oncology, Gene Expression Profiling, Single Nucleotide Polymorphism (SNP) Detection, Double-Stranded B-DNA Microarrays, Comparative Genomic Hybridization, Sequencing Bioinformatics), By End-User (Pharmaceutical And Biotechnological Companies, Research Organization, Hospitals) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Molecular Breeding Global Market Report 2024 – By Process (QTL Mapping, Marker-Assisted Selection, Marker-Assisted Backcrossing, Genomic Selection, Other Process), By Marker Type (Single Sequence Repeats (SSR), Single Nucleotide Polymorphism (SNP), Other Marker Type), By Application (Crop Breeding, Livestock Breeding) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Direct-To-Consumer (DTC) Genetic Testing Global Market Report 2024 – By Type (Carrier Testing, Predictive Testing, Ancestry And Relationship Testing, Nutrigenomic Testing, Other Types), By Sample (Saliva, Urine, Blood), By Technology (Single Nucleotide Polymorphism Chips, Whole Genome Sequencing, Targeted Analysis), By Business Model (Health Planning Model, Comprehensive Genome Tests Model, Medical Precision Tests Model, Restricted Trait Tests Mode), By End User (Laboratories, Blood Banks, Nursing Homes, Hospitals, Imaging Centers, Home Care, Cosmetics, Other End-User) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Poly-Vinyl Chloride Global Market Report 2024 – By Product Type (Rigid PVC, Flexible PVC, Low-smoke PVC, Chlorinated PVC), By Application (Pipes & Fittings, Film & Sheets, Wire & Cables, Bottles, Profiles, Hoses & Tubing, Other Applications), By End User Industry (Building & Construction, Automotive, Electrical & Electronics, Packaging, Footwear, Healthcare, Other End Use Industries) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Polybutadiene (BR) Global Market Report 2024 – By Product Type (Solid Polybutadiene, Liquid Polybutadiene), By Sales (Online, Offline), By Industry Vertical (Tire, Automotive, Chemical, Industry Rubber Manufacturing (Other Industry Verticals) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Polyethylene Terephthalate Global Market Report 2024 – By Product Type (Virgin, Recycle), By Application (Beverages, Sheets And Films, Consumer Goods, Food Packaging, Other Applications), By End-User Industry (Packaging, Electrical And Electronics, Automotive, Construction, Other End Uses Industries) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Polypropylene Global Market Report 2023 – By Product Type (Homopolymer, Copolymer), By Application (Injection Molding, Fiber and Raffia, Film and Sheet, Blow Molding), By End User Industry (Packaging, Automotive, Consumer Products, Electrical and Electronics, Other End-User Industries) – Market Size, Trends, And Global Forecast 2023-2032
View Report

Frequently Asked Questions

What is the definition of the single nucleotide polymorphism (SNP) genotyping market?

Single nucleotide polymorphism (SNP) genotyping refers to a procedure that locates and describes genetic variants at the level of specific DNA nucleotides. It identifies individual SNPs, which are single-base changes in DNA sequences, and it is essential for understanding the genetic variations linked to diseases, traits, and population studies. For further insights on the single nucleotide polymorphism (SNP) genotyping market, request a sample here

How will the single nucleotide polymorphism (SNP) genotyping market drivers and restraints affect the single nucleotide polymorphism (SNP) genotyping market dynamics? What forces will shape the single nucleotide polymorphism (SNP) genotyping industry goin

The single nucleotide polymorphism (SNP) genotyping market major growth driver - The Rising Role Of Snp Genotyping In Chronic Disease Management. For further insights on the single nucleotide polymorphism (SNP) genotyping market, request a sample here

What is the forecast market size or the forecast market value of the single nucleotide polymorphism (SNP) genotyping market?

The single nucleotide polymorphism (SNP) genotyping market size has grown exponentially in recent years. It will grow from $8.48 billion in 2023 to $10.24 billion in 2024 at a compound annual growth rate (CAGR) of 20.7%. The growth in the historic period can be attributed to increasing research in genomics, rise in genetic disorders, growth in personalized medicine, expanding pharmaceutical industry, rising demand for molecular diagnostics. The single nucleotide polymorphism (SNP) genotyping market size is expected to see rapid growth in the next few years. It will grow to $20.6 billion in 2028 at a compound annual growth rate (CAGR) of 19.1%. The growth in the forecast period can be attributed to growing applications in disease research, rise in demand for precision medicine, expanding biobanking initiatives, surge in genetic testing, rising adoption in agriculture for crop improvement. Major trends in the forecast period include increasing use of next-generation sequencing (ngs), rising demand for snp genotyping in pharmacogenomics, emergence of direct-to-consumer genetic testing, focus on automation and high-throughput genotyping platforms. For further insights on the single nucleotide polymorphism (SNP) genotyping market, request a sample here

How is the single nucleotide polymorphism (SNP) genotyping market segmented?

The single nucleotide polymorphism (SNP) genotyping market is segmented
1) By Product: Consumables, Instruments, services
2) By Technology: TaqMan SNP Genotyping, Mass Array SNP Genotyping, SNP Gene Chip Arrays, Other Technologies
3) By Application: Animal Genetics, Plant Improvement, Diagnostic Research, Pharmaceuticals And Pharmacogenomics, Agricultural Biotechnology, Other ApplicationsFor further insights on the single nucleotide polymorphism (SNP) genotyping market, request a sample here

Which region has the largest share of the single nucleotide polymorphism (SNP) genotyping market? What are the other regions covered in the report?

North America was the largest region in the single nucleotide polymorphism (SNP) genotyping market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the single nucleotide polymorphism (SNP) genotyping market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa For further insights on the single nucleotide polymorphism (SNP) genotyping market, request a sample here.

Who are the major players in the single nucleotide polymorphism (SNP) genotyping market?

Major companies operating in the single nucleotide polymorphism (SNP) genotyping market report are Thermo Fischer Scientific Inc., Danaher Corporation, Roche Diagnostics Corporation, GE HealthCare Technologies Inc., Eurofins Genomics LLC, Beckman Coulter Inc., Bio-Rad Laboratories Inc., Qiagen N.V., Sigma-Aldrich Corporation, Agilent Technologies Inc., PerkinElmer Inc., Illumina Inc., Promega Corporation, GenScript Biotech Corporation, Integrated DNA Technologies Inc., LGC Ltd., Sequenom Inc., Fluidigm Corporation, Agendia Inc., Nugen Technologies Inc., BioChain Institute Inc., Standard BioTools Inc., Oxford Gene Technology, Affymetrix Inc., PREMIER Biosoft International Inc., GenoLogics, Rubicon Genomics Inc., Xcelris Genomics, Douglas Scientific LLC, Golden Helix Inc. For further insights on the single nucleotide polymorphism (SNP) genotyping market, request a sample here.

What are the key trends in the single nucleotide polymorphism (SNP) genotyping market?

Major trend in the single nucleotide polymorphism (SNP) genotyping market - Neogen Corporation And Gencove Transforming Snp Genotyping With Infiniseek. For further insights on the single nucleotide polymorphism (SNP) genotyping market, request a sample here.

What are the major opportunities in the single nucleotide polymorphism (SNP) genotyping market? What are the strategies for the single nucleotide polymorphism (SNP) genotyping market?

For detailed insights on the major opportunities and strategies in the single nucleotide polymorphism (SNP) genotyping market, request a sample here.

How does the single nucleotide polymorphism (SNP) genotyping market relate to the overall economy and other similar markets?

For detailed insights on single nucleotide polymorphism (SNP) genotyping market's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the single nucleotide polymorphism (SNP) genotyping industry?

For detailed insights on the mergers and acquisitions in the single nucleotide polymorphism (SNP) genotyping industry, request a sample here.

What are the key dynamics influencing the single nucleotide polymorphism (SNP) genotyping market growth? SWOT analysis of the single nucleotide polymorphism (SNP) genotyping market.

For detailed insights on the key dynamics influencing the single nucleotide polymorphism (SNP) genotyping market growth and SWOT analysis of the single nucleotide polymorphism (SNP) genotyping industry, request a sample here.